Phage therapy program
Tabula Bioscience
| Status | Official referral/inquiry route |
|---|---|
| Type | Company |
| Location | San Francisco, California / Madison, Wisconsin (listed work sites); United States |
| Entry review | 2026-10-03 |
Access and enquiries
| How to enquire | Policy updated July 2026 accepts physician or patient inquiries at expandedaccess@tabulabio.com. Do not send protected health information in general email; company provides secure-transmission instructions if needed. Company says physician inquiries will be acknowledged within two business days and reviewed after sufficient information within five. |
|---|---|
| Areas of work | Investigational individualized phage therapies; serious bacterial infections without satisfactory alternatives and infeasible trial participation; isolate matching, manufacturing capacity and regulatory/ethical requirements determine supply. |
| International access | Policy describes US FDA expanded access; international patient/supply eligibility is not specified. |
What to confirm
- Published policy does not guarantee product, company approval, FDA authorization or treatment. Corporate headquarters not confirmed; city field records advertised work sites. No recruiting population trial independently verified.
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Program ID | tabula |
|---|